🔗 Permalink

Inventor profile of:

Alan Kozikowski

City:

Chicago, Illinois

Country:

United States

Published Applications:

Last publication date:

2025-02-20

Top Assignees for applications by Alan Kozikowski

The entities that hold a legal rights for patent applications filed by inventor Kozikowski Alan:

The Board of Trustees of the University of Illinois 11 Urbana, IL United States
The University of North Carolina at Chapel Hill 2 Chapel Hill, NC United States
H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. 2 Tampa, FL United States
BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2 Urbana, IL United States
The University of North Carolina at Chapel Hikll 1 Chapel Hill, NC United States
THE UNIVERSITY OF CHICAGO 1 Chicago, IL United States
The Children's Hospital of Philadelphia 1 Philadelphia, PA United States
The Board of Trustees of the University of Illinos 1 Urbana, IL United States

Recent patent applications by Kozikowski Alan

Alan Kozikowski from Chicago, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-02-20

US20250059217A1

Chemistry; metallurgy

HETEROCYCLIC COMPOUNDS AND METHODS OF PREPARATION THEREOF

#2 | 2023-08-10

US20230250054A1

Chemistry; metallurgy

SELECTIVE HISTONE DEACETYLASE 6 INHIBITORS

#3 | 2023-05-04

US20230140635A1

Chemistry; metallurgy

3-(2-(Aminoethyl)-Indol-4-ol Derivatives, Methods of Preparation Thereof, and the Use as 5-HT2 Receptor Modulators

#4 | 2021-05-13

US20210139438A1

Chemistry; metallurgy

HDAC inhibitors and therapeutic methods using the same

#5 | 2020-02-06

US20200039933A1

Chemistry; metallurgy

Nrf and HIF activators/HDAC inhibitors and therapeutic methods using the same

#6 | 2019-08-22

US20190255046A1

Human necessities

Tetrahydroquinoline substituted hydroxamic acids as selective histone deacetylase 6 inhibitors

#7 | 2019-03-21

US20190083491A1

Human necessities

Small molecules inhibitors of RAD51

#8 | 2019-01-24

US20190023670A1

Chemistry; metallurgy

HDAC inhibitors and therapeutic methods using the same

#9 | 2018-09-20

US20180265453A1

Chemistry; metallurgy

Cyclopropylmethanamines as selective 5-HT(2C) receptor agonists

#10 | 2017-02-16

US20170044100A1

Chemistry; metallurgy

INHIBITORS OF DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS

#11 | 2017-02-09

US20170035710A1

Human necessities

Selective histone deactylase 6 inhibitors

#12 | 2015-02-26

US20150056213A1

Chemistry; metallurgy

Selective histone deactylase 6 inhibitors

#13 | 2014-05-08

US20140128408A1

Chemistry; metallurgy

HDAC inhibitors and therapeutic methods using the same

#14 | 2013-10-24

US20130281539A1

Chemistry; metallurgy

Highly selective 5-HT(2C) receptor agonists that show anti-psychotic effects with antagonist activity at the 5-HT(2B) receptor

#15 | 2013-10-24

US20130281484A1

Chemistry; metallurgy

HDAC inhibitors and therapeutic methods of using same

#16 | 2013-03-28

US20130079417A1

Human necessities

Highly selective 5-HT(2C) receptor agonists that show anti-psychotic effects with antagonist activity at the 5-HT(2B) receptor

#17 | 2012-10-04

US20120252740A1

Chemistry; metallurgy

HDAC inhibitors and therapeutic methods of using same

#18 | 2011-10-20

US20110257145A1

Chemistry; metallurgy

METHOD OF TREATING NEUROLOGICAL DISEASES

#19 | 2009-08-13

US20090203750A1

Chemistry; metallurgy

5-HT2C Receptor Agonists as Anorectic Agents

InventorID:

167671 ⎘